Literature DB >> 9070917

PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13.

G Matthijs1, E Schollen, M Pirard, M L Budarf, E Van Schaftingen, J J Cassiman.   

Abstract

We have cloned the human homologue of SEC53 or yeast phosphomannomutase (HGMW-approved symbol PMM1) from a liver cDNA library. This cDNA encodes a protein of 262 amino acids with a predicted molecular mass of 29 kDa and 54% identity with yeast phosphomannomutase. Expression of the human cDNA in Escherichia coli yielded an active phosphomannomutase, which was purified to homogeneity. Northern blot analysis of human tissues showed strong expression in liver, heart, brain, and pancreas and a lower expression in skeletal muscle. The gene was assigned to chromosome 22q13.1 by the use of hybrid cell lines and by fluorescence in situ hybridization. Most patients presenting with carbohydrate-deficient glycoprotein syndrome type 1 (CDG1 or Jaeken disease) have a greatly reduced phosphomannomutase activity; the gene encoding this enzyme is a likely candidate for CDG1. Since the CDG1 locus maps else where in the genome (16p13), mutations in the phosphomannomutase gene encoded by chromosome 22 are not a major cause of CDG1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070917     DOI: 10.1006/geno.1996.4536

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Ontogeny of D-mannose transport and metabolism in rat small intestine.

Authors:  Mecedes Cano; Anunciación A Ilundain
Journal:  J Membr Biol       Date:  2010-06-04       Impact factor: 1.843

Review 2.  Carbohydrate-deficient glycoprotein syndromes.

Authors:  N Gordon
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

3.  Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1.

Authors:  F Imtiaz; V Worthington; M Champion; C Beesley; J Charlwood; P Clayton; G Keir; N Mian; B Winchester
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

4.  Molecular cloning and functional analysis of the phosphomannomutase (PMM) gene from Dendrobium officinale and evidence for the involvement of an abiotic stress response during germination.

Authors:  Chunmei He; Songjun Zeng; Jaime A Teixeira da Silva; Zhenming Yu; Jianwen Tan; Jun Duan
Journal:  Protoplasma       Date:  2016-12-16       Impact factor: 3.356

5.  Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants.

Authors:  A Garami; A Mehlert; T Ilg
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes.

Authors:  M Pirard; Y Achouri; J F Collet; E Schollen; G Matthijs; E Van Schaftingen
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

7.  Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A.

Authors:  G Matthijs; E Schollen; E Van Schaftingen; J J Cassiman; J Jaeken
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

8.  The normal phenotype of Pmm1-deficient mice suggests that Pmm1 is not essential for normal mouse development.

Authors:  K Cromphout; W Vleugels; L Heykants; E Schollen; L Keldermans; R Sciot; R D'Hooge; P P De Deyn; K von Figura; D Hartmann; C Körner; G Matthijs
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

9.  Evolutionary history and functional diversification of phosphomannomutase genes.

Authors:  Rita Quental; Ana Moleirinho; Luísa Azevedo; António Amorim
Journal:  J Mol Evol       Date:  2010-07-27       Impact factor: 2.395

10.  Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-1,6-bisphosphatase.

Authors:  Maria Veiga-da-Cunha; Wendy Vleugels; Pushpa Maliekal; Gert Matthijs; Emile Van Schaftingen
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.